Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

22.08.2022

9 Ann Intern Med
2 Antimicrob Agents Chemother
4 Antiviral Res
7 BMJ
1 J Clin Microbiol
1 J Exp Med
2 J Immunol
35 J Infect Dis
1 J Virol
2 J Virol Methods
4 JAMA
1 Lancet
2 MMWR Morb Mortal Wkly Rep
2 Pediatrics
1 PLoS Biol
3 PLoS Comput Biol
1 PLoS Med
36 PLoS One
5 Proc Natl Acad Sci U S A
20 Vaccine



    Ann Intern Med

  1. KAKA AS, Wilt TJ
    Major Update 2: Remdesivir for Adults With COVID-19.
    Ann Intern Med. 2022;175:W81-W82.
    >> Share

  2. FINSTERER J
    Major Update 2: Remdesivir for Adults With COVID-19.
    Ann Intern Med. 2022;175:W81.
    >> Share

  3. MONTORI VM
    Patients surviving COVID-19 had increased risk for incident diabetes vs. persons without COVID-19.
    Ann Intern Med. 2022 Aug 2. doi: 10.7326/J22-0052.
    >> Share

  4. BROPHY JM
    mRNA COVID-19 vaccines were linked to myocarditis at 28 d (0.15 to 10 excess events/100 000 vaccinated persons).
    Ann Intern Med. 2022 Aug 2. doi: 10.7326/J22-0057.
    >> Share

  5. AISENBERG GM
    In persons at risk for poor vaccination response or COVID-19 exposure, tixagevimab + cilgavimab reduced COVID-19.
    Ann Intern Med. 2022 Aug 2. doi: 10.7326/J22-0056.
    >> Share

  6. CROWLEY R, Atiq O, Hilden D
    Long-Term Services and Supports for Older Adults: A Position Paper From the American College of Physicians.
    Ann Intern Med. 2022 Jul 12. doi: 10.7326/M22-0864.
    >> Share

  7. SERCHEN J, Atiq O, Hilden D
    Strengthening Food and Nutrition Security to Promote Public Health in the United States: A Position Paper From the American College of Physicians.
    Ann Intern Med. 2022 Jun 28. doi: 10.7326/M22-0390.
    >> Share

  8. PALMORE TN, Henderson DK
    Adding New Fuel to the Fire: Monkeypox in the Time of COVID-19-Implications for Health Care Personnel.
    Ann Intern Med. 2022 Jun 14. doi: 10.7326/M22-1763.
    >> Share

  9. JOHNSON MG, Puenpatom A, Moncada PA, Burgess L, et al
    Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial.
    Ann Intern Med. 2022 Jun 7. doi: 10.7326/M22-0729.
    >> Share


    Antimicrob Agents Chemother

  10. ATMAR RL, Finch N
    New Perspectives on Antimicrobial Agents: Molnupiravir and Nirmatrelvir/Ritonavir for Treatment of COVID-19.
    Antimicrob Agents Chemother. 2022 Jul 12:e0240421. doi: 10.1128/aac.02404.
    >> Share

  11. LAPAILLERIE D, Charlier C, Guyonnet-Duperat V, Murigneux E, et al
    Selection of Bis-Indolyl Pyridines and Triphenylamines as New Inhibitors of SARS-CoV-2 Cellular Entry by Modulating the Spike Protein/ACE2 Interfaces.
    Antimicrob Agents Chemother. 2022;66:e0008322.
    >> Share


    Antiviral Res

  12. LI M, Chen J, Liu Y, Zhao J, et al
    Rational design of AAVrh10-vectored ACE2 functional domain to broadly block the cell entry of SARS-CoV-2 variants.
    Antiviral Res. 2022 Jul 30:105383. doi: 10.1016/j.antiviral.2022.105383.
    >> Share

  13. SAMRAT SK, Xu J, Xie X, Gianti E, et al
    Allosteric inhibitors of the main protease of SARS-CoV-2.
    Antiviral Res. 2022;205:105381.
    >> Share

  14. BEZERRA BB, Silva GPDD, Antunes Coelho SV, Correa IA, et al
    Hydroxypropyl-beta-cyclodextrin (HP-BCD) inhibits SARS-CoV-2 replication and virus-induced inflammatory cytokines.
    Antiviral Res. 2022 Jul 4:105373. doi: 10.1016/j.antiviral.2022.105373.
    >> Share

  15. OHASHI H, Hishiki T, Akazawa D, Kim KS, et al
    Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2.
    Antiviral Res. 2022 Jul 4:105372. doi: 10.1016/j.antiviral.2022.105372.
    >> Share


    BMJ

  16. MAHASE E
    Covid-19: UK will roll out Moderna's omicron BA.1 vaccine as part of autumn booster programme.
    BMJ. 2022;378:o2038.
    >> Share

  17. WISE J
    Covid-19: What have been the direct and indirect health impacts in England?
    BMJ. 2022;378:o2045.
    >> Share

  18. OLIVER D
    David Oliver: The overwhelming reaction to my personal covid story.
    BMJ. 2022;378:o2017.
    >> Share

  19. FELL DB, Dimanlig-Cruz S, Regan AK, Haberg SE, et al
    Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study.
    BMJ. 2022;378:e071416.
    >> Share

  20. WISE J
    Covid-19: Increased risk of some neurological and psychiatric disorders remains two years after infection, study finds.
    BMJ. 2022;378:o2048.
    >> Share

  21. MAHASE E
    Covid-19: UK will not buy Evusheld owing to "insufficient data" on protection, government says.
    BMJ. 2022;378:o2021.
    >> Share

  22. WISE J
    Covid-19: Study provides further evidence that mRNA vaccines are safe in pregnancy.
    BMJ. 2022;378:o2013.
    >> Share


    J Clin Microbiol

  23. LEBER AL, Peterson E, Dien Bard J
    The Hidden Crisis in the Times of COVID-19: Critical Shortages of Medical Laboratory Professionals in Clinical Microbiology.
    J Clin Microbiol. 2022;60:e0024122.
    >> Share


    J Exp Med

  24. LIM JME, Tan AT, Le Bert N, Hang SK, et al
    SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity.
    J Exp Med. 2022;219.
    >> Share


    J Immunol

  25. LUAN Y, Yuan Q, Wang Q, Compton S, et al
    Pazopanib Is a Potential Treatment for Coronavirus-Induced Lung Injuries.
    J Immunol. 2022;209:723-730.
    >> Share

  26. CAMPANA S, De Pasquale C, Sidoti Migliore G, Pezzino G, et al
    Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients.
    J Immunol. 2022;209:655-659.
    >> Share


    J Infect Dis

  27. GREEN WD, Alwarawrah Y, Al-Shaer AE, Shi Q, et al
    Inflammation and metabolism of influenza-stimulated PBMCs from adults with obesity following bariatric surgery.
    J Infect Dis. 2022 Aug 17. pii: 6670556. doi: 10.1093.
    >> Share

  28. SUH M, Movva N, Jiang X, Reichert H, et al
    Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011-2019.
    J Infect Dis. 2022;226.
    >> Share

  29. SUH M, Movva N, Jiang X, Bylsma LC, et al
    Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009-2019: A Study of the National (Nationwide) Inpatient Sample.
    J Infect Dis. 2022;226.
    >> Share

  30. REICHERT H, Suh M, Jiang X, Movva N, et al
    Mortality Associated With Respiratory Syncytial Virus, Bronchiolitis, and Influenza Among Infants in the United States: A Birth Cohort Study From 1999 to 2018.
    J Infect Dis. 2022;226.
    >> Share

  31. SUH M, Movva N, Bylsma LC, Fryzek JP, et al
    A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year.
    J Infect Dis. 2022;226.
    >> Share

  32. BOWSER DM, Rowlands KR, Hariharan D, Gervasio RM, et al
    Cost of Respiratory Syncytial Virus Infections in US Infants: Systematic Literature Review and Analysis.
    J Infect Dis. 2022;226.
    >> Share

  33. MOVVA N, Suh M, Bylsma LC, Fryzek JP, et al
    Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age.
    J Infect Dis. 2022;226.
    >> Share

  34. GLASER EL, Hariharan D, Bowser DM, Gervasio RM, et al
    Impact of Respiratory Syncytial Virus on Child, Caregiver, and Family Quality of Life in the United States: Systematic Literature Review and Analysis.
    J Infect Dis. 2022;226.
    >> Share

  35. HANSEN CL, Viboud C, Chaves SS
    The Use of Death Certificate Data to Characterize Mortality Associated With Respiratory Syncytial Virus, Unspecified Bronchiolitis, and Influenza in the United States, 1999-2018.
    J Infect Dis. 2022;226.
    >> Share

  36. BYLSMA LC, Suh M, Movva N, Fryzek JP, et al
    Mortality Among US Infants and Children Under 5 Years of Age with Respiratory Syncytial Virus and Bronchiolitis: A Systematic Literature Review.
    J Infect Dis. 2022;226.
    >> Share

  37. HODGES EN, White M, Nelson CB
    All Infants Are at Risk of Developing Medically Attended Respiratory Syncytial Virus Lower Respiratory Tract Infection and Deserve Protection.
    J Infect Dis. 2022;226.
    >> Share

  38. GANTENBERG JR, van Aalst R, Zimmerman N, Limone B, et al
    Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020.
    J Infect Dis. 2022;226.
    >> Share

  39. MOVVA N, Suh M, Reichert H, Hintze B, et al
    Respiratory Syncytial Virus During the COVID-19 Pandemic Compared to Historic Levels: A Retrospective Cohort Study of a Health System.
    J Infect Dis. 2022;226.
    >> Share

  40. SIMOES EAF
    The Burden of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Synthesis.
    J Infect Dis. 2022;226.
    >> Share

  41. KIEFFER A, Beuvelet M, Sardesai A, Musci R, et al
    Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model.
    J Infect Dis. 2022;226.
    >> Share

  42. GOMEZ GB, Nelson CB, Rizzo C, Shepard DS, et al
    Inequalities in Health Impact of Alternative Reimbursement Pathways for Nirsevimab in the United States.
    J Infect Dis. 2022;226.
    >> Share

  43. MCGINLEY JP, Lin GL, Oner D, Golubchik T, et al
    Clinical and Viral Factors Associated With Disease Severity and Subsequent Wheezing in Infants With Respiratory Syncytial Virus Infection.
    J Infect Dis. 2022;226.
    >> Share

  44. SIMOES EAF
    Respiratory Syncytial Virus Disease in Young Children and Older Adults in Europe: A Burden and Economic Perspective.
    J Infect Dis. 2022;226.
    >> Share

  45. JOHANNESEN CK, van Wijhe M, Tong S, Fernandez LV, et al
    Age-Specific Estimates of Respiratory Syncytial Virus-Associated Hospitalizations in 6 European Countries: A Time Series Analysis.
    J Infect Dis. 2022;226.
    >> Share

  46. DERKSEN-LAZET ND, Parmentier CEJ, Wildenbeest JG, Bont LJ, et al
    Patient Involvement in RSV Research: Towards Patients Setting the Research Agenda.
    J Infect Dis. 2022;226.
    >> Share

  47. WANG X, Li Y, Shi T, Ma Y, et al
    Global Disease Burden of Respiratory Syncytial Virus in Preterm Children in 2019: A Systematic Review and Individual Participant Data Meta-Analysis Protocol.
    J Infect Dis. 2022;226.
    >> Share

  48. VAN WIJHE M, Johannesen CK, Simonsen L, Jorgensen IM, et al
    A Retrospective Cohort Study on Infant Respiratory Tract Infection Hospitalizations and Recurrent Wheeze and Asthma Risk: Impact of Respiratory Syncytial Virus.
    J Infect Dis. 2022;226.
    >> Share

  49. REEVES RM, van Wijhe M, Lehtonen T, Stona L, et al
    A Systematic Review of European Clinical Practice Guidelines for Respiratory Syncytial Virus Prophylaxis.
    J Infect Dis. 2022 Mar 25. pii: 6554001. doi: 10.1093.
    >> Share

  50. GUISADO-VASCO P, Aguarles Gorines J, Carralon Gonzalez MM, Sotres Fernandez G, et al
    Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019.
    J Infect Dis. 2022;226:1-5.
    >> Share

  51. LI X, Bilcke J, Vazquez Fernandez L, Bont L, et al
    Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian Children.
    J Infect Dis. 2022 Mar 16. pii: 6549175. doi: 10.1093.
    >> Share

  52. KAO CC, Liaw YP
    Comment on " Infants Younger Than 6 Months Infected With SARS-CoV-2 Show the Highest Respiratory Viral Loads".
    J Infect Dis. 2022;226:188.
    >> Share

  53. HARALAMBIEVA IH, Monroe JM, Ovsyannikova IG, Grill DE, et al
    Distinct Homologous and Variant-Specific Memory B-Cell and Antibody Response Over Time after SARS-CoV-2 mRNA Vaccination.
    J Infect Dis. 2022 Feb 8. pii: 6524526. doi: 10.1093.
    >> Share

  54. ZUURBIER RP, Korsten K, Verheij TJM, Butler C, et al
    Performance Assessment of a Rapid Molecular Respiratory Syncytial Virus Point-of-Care Test: A Prospective Community Study in Older Adults.
    J Infect Dis. 2022;226.
    >> Share

  55. KIM N, Shin S, Minn D, Park S, et al
    SARS-CoV-2 Infectivity and Antibody Titer Reduction for 6 Months After Second Dose of BNT162b2 mRNA Vaccine in Healthcare Workers: A Prospective Cohort Study.
    J Infect Dis. 2022 Feb 1. pii: 6519374. doi: 10.1093.
    >> Share

  56. SKOWRONSKI DM, Setayeshgar S, Zou M, Prystajecky N, et al
    Comparative single-dose mRNA and ChAdOx1 vaccine effectiveness against SARS-CoV-2, including variants of concern: test-negative design, British Columbia, Canada.
    J Infect Dis. 2022 Jan 27. pii: 6515934. doi: 10.1093.
    >> Share

  57. WANG X, Li Y, Vazquez Fernandez L, Teirlinck AC, et al
    Respiratory Syncytial Virus-Associated Hospital Admissions and Bed Days in Children <5 Years of Age in 7 European Countries.
    J Infect Dis. 2022;226.
    >> Share

  58. MCGINLEY J, Thwaites R, Brebner W, Greenan-Barrett L, et al
    A Systematic Review and Meta-analysis of Animal Studies Investigating the Relationship Between Serum Antibody, T Lymphocytes, and Respiratory Syncytial Virus Disease.
    J Infect Dis. 2022;226.
    >> Share

  59. WANG X, Li Y, Nair H, Campbell H, et al
    Time-Varying Association Between Severe Respiratory Syncytial Virus Infections and Subsequent Severe Asthma and Wheeze and Influences of Age at the Infection.
    J Infect Dis. 2022;226.
    >> Share

  60. SHI T, Vennard S, Jasiewicz F, Brogden R, et al
    Disease Burden Estimates of Respiratory Syncytial Virus related Acute Respiratory Infections in Adults With Comorbidity: A Systematic Review and Meta-Analysis.
    J Infect Dis. 2022;226.
    >> Share

  61. SHI T, Vennard S, Mahdy S, Nair H, et al
    Risk Factors for Poor Outcome or Death in Young Children With Respiratory Syncytial Virus-Associated Acute Lower Respiratory Tract Infection: A Systematic Review and Meta-Analysis.
    J Infect Dis. 2022;226.
    >> Share


    J Virol

  62. AKAISHI T, Horii A, Ishii T
    Sequence Exchange Involving Dozens of Consecutive Bases with External Origin in SARS-Related Coronaviruses.
    J Virol. 2022 Jul 20:e0100222. doi: 10.1128/jvi.01002.
    >> Share


    J Virol Methods

  63. SMITH M, El Bouzidi K, Bengen S, Cohen A, et al
    Potential pitfalls in analysing a SARS-CoV-2 RT-PCR assay and how to standardise data interpretation.
    J Virol Methods. 2022;308:114589.
    >> Share

  64. DOS SANTOS CARNEIRO M, Volpato FCZ, Wink PL, Pereira DC, et al
    Evaluation of filter paper to transport oro/nasopharyngeal samples to detect SARS-CoV-2 by RT-qPCR.
    J Virol Methods. 2022;308:114587.
    >> Share


    JAMA

  65. RUBIN R
    Pharmacists Allowed to Prescribe COVID-19 Antiviral.
    JAMA. 2022;328:612.
    >> Share

  66. LO RE V 3RD, Dutcher SK, Connolly JG, Perez-Vilar S, et al
    Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients.
    JAMA. 2022;328:637-651.
    >> Share

  67. LARKIN HD
    Preventing COVID-19, Saving Lives in Lower-Income Countries.
    JAMA. 2022;328:611.
    >> Share

  68. AZZOLINI E, Levi R, Sarti R, Pozzi C, et al
    Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers.
    JAMA. 2022 Jul 1. pii: 2794072. doi: 10.1001/jama.2022.11691.
    >> Share


    Lancet

  69. MELLO MM, Opel DJ, Benjamin RM, Callaghan T, et al
    Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA.
    Lancet. 2022 Jul 8. pii: S0140-6736(22)00875.
    >> Share


    MMWR Morb Mortal Wkly Rep

  70. SHIRCLIFF EJ, Rosenberg ES, Collens LM, Hoefer D, et al
    Notes from the Field: School-Based and Laboratory-Based Reporting of Positive COVID-19 Test Results Among School-Aged Children - New York, September 11, 2021-April 29, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1029-1031.
    >> Share

  71. RITCHEY MD, Rosenblum HG, Del Guercio K, Humbard M, et al
    COVID-19 Self-Test Data: Challenges and Opportunities - United States, October 31, 2021-June 11, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1005-1010.
    >> Share


    Pediatrics

  72. ORTIZ RR, Coyne-Beasley T
    Personalized Texts Can Boost Receipt of Second Influenza Shot for Young Children.
    Pediatrics. 2022 Aug 15. pii: 188763. doi: 10.1542/peds.2022-057363.
    >> Share

  73. STOCKWELL MS, Shone LP, Nekrasova E, Wynn C, et al
    Text Message Reminders for the Second Dose of Influenza Vaccine for Children: An RCT.
    Pediatrics. 2022 Aug 15. pii: 188765. doi: 10.1542/peds.2022-056967.
    >> Share


    PLoS Biol

  74. ZHU Y, Chew KY, Wu M, Karawita AC, et al
    Ancestral SARS-CoV-2, but not Omicron, replicates less efficiently in primary pediatric nasal epithelial cells.
    PLoS Biol. 2022;20:e3001728.
    >> Share


    PLoS Comput Biol

  75. BARRAT-CHARLAIX P, Vaughan TG, Neher RA
    TreeKnit: Inferring ancestral reassortment graphs of influenza viruses.
    PLoS Comput Biol. 2022;18:e1010394.
    >> Share

  76. YIN S, Xu Y, Xu M, de Jong MCM, et al
    Habitat loss exacerbates pathogen spread: An Agent-based model of avian influenza infection in migratory waterfowl.
    PLoS Comput Biol. 2022;18:e1009577.
    >> Share

  77. HEITZMAN-BREEN N, Ciupe SM
    Modeling within-host and aerosol dynamics of SARS-CoV-2: The relationship with infectiousness.
    PLoS Comput Biol. 2022;18:e1009997.
    >> Share


    PLoS Med

  78. KIM S, Headley TY, Tozan Y
    Universal healthcare coverage and health service delivery before and during the COVID-19 pandemic: A difference-in-difference study of childhood immunization coverage from 195 countries.
    PLoS Med. 2022;19:e1004060.
    >> Share


    PLoS One

  79. AFRIFA-ANANE GF, Larbi RT, Addo B, Agyekum MW, et al
    Facilitators and barriers to COVID-19 vaccine uptake among women in two regions of Ghana: A qualitative study.
    PLoS One. 2022;17:e0272876.
    >> Share

  80. CRUZ M, Pinho S, Castro-Lopes JM, Sampaio R, et al
    Patients and healthcare professionals perspectives on creating a chronic pain support line in Portugal: A qualitative study protocol.
    PLoS One. 2022;17:e0273213.
    >> Share

  81. FURAR E, Wang F, Durocher JS, Ahn YA, et al
    The impact of COVID-19 on individuals with ASD in the US: Parent perspectives on social and support concerns.
    PLoS One. 2022;17:e0270845.
    >> Share

  82. LORTHE E, Bellon M, Michielin G, Berthelot J, et al
    Epidemiological, virological and serological investigation of a SARS-CoV-2 outbreak (Alpha variant) in a primary school: A prospective longitudinal study.
    PLoS One. 2022;17:e0272663.
    >> Share

  83. KHAN ZS, Van Bussel F, Hussain F
    Modeling the change in European and US COVID-19 death rates.
    PLoS One. 2022;17:e0268332.
    >> Share

  84. BALGOPAL MM, Weinberg AE, Sample McMeeking LB, Lin Hunter DE, et al
    A sense of belonging: The role of higher education in retaining quality STEM teachers.
    PLoS One. 2022;17:e0272552.
    >> Share

  85. DENSLOW S, Wingert JR, Hanchate AD, Rote A, et al
    Rural-urban outcome differences associated with COVID-19 hospitalizations in North Carolina.
    PLoS One. 2022;17:e0271755.
    >> Share

  86. HUSAIN F, Powys VR, White E, Jones R, et al
    COVID-19 vaccination uptake in 441 socially and ethnically diverse pregnant women.
    PLoS One. 2022;17:e0271834.
    >> Share

  87. SAGI J, Lentner C
    Key issues in the effectiveness of public financial tools to support childbearing the example of Hungary during the COVID-19 crisis.
    PLoS One. 2022;17:e0273090.
    >> Share

  88. ARGUNI E, Dewi FST, Fachiroh J, Paramita DK, et al
    Two-years antibody responses following SARS-CoV-2 infection in humans: A study protocol.
    PLoS One. 2022;17:e0272690.
    >> Share

  89. OKONOFUA FE, Ntoimo LFC, Onoh VI, Omonkhua AA, et al
    Lived experiences of recovered COVID-19 persons in Nigeria: A phenomenological study.
    PLoS One. 2022;17:e0268109.
    >> Share

  90. RAMASAWMY M, Mu Y, Clutterbuck D, Pantelic M, et al
    STIMULATE-ICP-CAREINEQUAL (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways) study protocol: Defining usual care and examining inequalities in Long Covid support.
    PLoS One. 2022;17:e0271978.
    >> Share

  91. ASHAMO AY, Bekele A, Petrose A, Gebreyes T, et al
    Assessment of hypertension and other factors associated with the severity of disease in COVID-19 pneumonia, Addis Ababa, Ethiopia: A case-control study.
    PLoS One. 2022;17:e0273012.
    >> Share

  92. CORTES-SARABIA K, Cruz-Rangel A, Flores-Alanis A, Salazar-Garcia M, et al
    Clinical features and severe acute respiratory syndrome-coronavirus-2 structural protein-based serology of Mexican children and adolescents with coronavirus disease 2019.
    PLoS One. 2022;17:e0273097.
    >> Share

  93. SPANYIK A, Simon D, Rigo A, Griffiths MD, et al
    Subjective COVID-19-related work factors predict stress, burnout, and depression among healthcare workers during the COVID-19 pandemic but not objective factors.
    PLoS One. 2022;17:e0270156.
    >> Share

  94. SCHORR O, Blach S, Thurnheer C, Ruis C, et al
    Modelling the microelimination of chronic hepatitis C in the canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy goals despite the impact of the COVID 19 pandemic.
    PLoS One. 2022;17:e0272518.
    >> Share

  95. LEI J, Clements M, Elfstrom M, Lundgren KC, et al
    Predicting past and future SARS-CoV-2-related sick leave using discrete time Markov modelling.
    PLoS One. 2022;17:e0273003.
    >> Share

  96. CHEN J, Chou SY, Yu TH, Rizqi ZU, et al
    System dynamics analysis on the effectiveness of vaccination and social mobilization policies for COVID-19 in the United States.
    PLoS One. 2022;17:e0268443.
    >> Share

  97. ALASMARI F, Mukahal M, Alqurashi AA, Huq M, et al
    Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
    PLoS One. 2022;17:e0272818.
    >> Share

  98. YAN BW, Shashoua M, Figueroa JF
    Changes in spending, utilization, and quality of care among Medicare accountable care organizations during the COVID-19 pandemic.
    PLoS One. 2022;17:e0272706.
    >> Share

  99. VIGON L, Galan M, Torres M, Martin-Galiano AJ, et al
    Association between HLA-C alleles and COVID-19 severity in a pilot study with a Spanish Mediterranean Caucasian cohort.
    PLoS One. 2022;17:e0272867.
    >> Share

  100. SHUI X, Wang F, Li L, Liang Q, et al
    COVID-19 vaccine acceptance among healthcare workers in China: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0273112.
    >> Share

  101. HUTTELMAIER MT, Gabel A, Seewald M, Jungbauer C, et al
    Impact of coronavirus disease (COVID-19) pandemic on physical activity of patients with cardiac implantable electronic devices-A remote monitoring study.
    PLoS One. 2022;17:e0269816.
    >> Share

  102. RUTGERS A, Westerweel PE, van der Holt B, Postma S, et al
    Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients.
    PLoS One. 2022;17:e0271807.
    >> Share

  103. NGUYEN DT, Ngo TM, Nguyen HLT, Le MD, et al
    The prevalence of self-reported anxiety, depression, and associated factors among Hanoi Medical University's students during the first wave of COVID-19 pandemic.
    PLoS One. 2022;17:e0269740.
    >> Share

  104. KIM SW, Santia M, Pingree RJ, Oden A, et al
    The curve not taken: Effects of COVID-19 international comparison news.
    PLoS One. 2022;17:e0271041.
    >> Share

  105. NOHARA Y, Manabe T
    Impact of human mobility and networking on spread of COVID-19 at the time of the 1st and 2nd epidemic waves in Japan: An effective distance approach.
    PLoS One. 2022;17:e0272996.
    >> Share

  106. KOENS S, Strauss A, Klein J, Schafer I, et al
    Public perceptions of urgency of severe cases of COVID-19 and inflammatory gastrointestinal disease.
    PLoS One. 2022;17:e0273000.
    >> Share

  107. TEKLE E, Gelaw Y, Dagnew M, Gelaw A, et al
    Risk stratification and prognostic value of prothrombin time and activated partial thromboplastin time among COVID-19 patients.
    PLoS One. 2022;17:e0272216.
    >> Share

  108. DUMONT R, Richard V, Baysson H, Lorthe E, et al
    Determinants of adolescents' Health-Related Quality of Life and psychological distress during the COVID-19 pandemic.
    PLoS One. 2022;17:e0272925.
    >> Share

  109. LEONE V, Meisinger C, Temizel S, Kling E, et al
    Longitudinal change in SARS-CoV-2 seroprevalence in 3-to 16-year-old children: The Augsburg Plus study.
    PLoS One. 2022;17:e0272874.
    >> Share

  110. NICHOLS ES, Pathak HS, Bgeginski R, Mottola MF, et al
    Machine learning-based predictive modeling of resilience to stressors in pregnant women during COVID-19: A prospective cohort study.
    PLoS One. 2022;17:e0272862.
    >> Share

  111. APENYO T, Vera-Urbina AE, Ahmad K, Taveira TH, et al
    Association between median household income, state Medicaid expansion status, and COVID-19 outcomes across US counties.
    PLoS One. 2022;17:e0272497.
    >> Share

  112. MANANDHAR SHRESTHA R, Inoue Y, Fukunaga A, Hoang DV, et al
    Infection prevention practices and its associated factors among hospital workers in a national medical center designated for COVID-19 in Tokyo, Japan.
    PLoS One. 2022;17:e0272856.
    >> Share

  113. FREDIANI JK, McLendon KB, Westbrook A, Gillespie SE, et al
    SARS-CoV-2 reliably detected in frozen saliva samples stored up to one year.
    PLoS One. 2022;17:e0272971.
    >> Share

  114. ABEBE HT, Mulugeta A, Berhe Y, Berhane K, et al
    Risk factors for mortality among hospitalized COVID-19 patients in Northern Ethiopia: A retrospective analysis.
    PLoS One. 2022;17:e0271124.
    >> Share


    Proc Natl Acad Sci U S A

  115. XIONG H, Sun H, Wang S, Yuan L, et al
    The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2022;119:e2204256119.
    >> Share

  116. MENG F, Yang H, Qu Z, Chen Y, et al
    A Eurasian avian-like H1N1 swine influenza reassortant virus became pathogenic and highly transmissible due to mutations in its PA gene.
    Proc Natl Acad Sci U S A. 2022;119:e2203919119.
    >> Share

  117. CHEN J, Ye Z, Huang C, Qiu M, et al
    Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8(+) T cell response.
    Proc Natl Acad Sci U S A. 2022;119:e2207841119.
    >> Share

  118. WANG X, Du Z, James E, Fox SJ, et al
    The effectiveness of COVID-19 testing and contact tracing in a US city.
    Proc Natl Acad Sci U S A. 2022;119:e2200652119.
    >> Share

  119. CRUNFLI F, Carregari VC, Veras FP, Silva LS, et al
    Morphological, cellular, and molecular basis of brain infection in COVID-19 patients.
    Proc Natl Acad Sci U S A. 2022;119:e2200960119.
    >> Share


    Vaccine

  120. MCMILLAN CLD, Amarilla AA, Modhiran N, Choo JJY, et al
    Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern.
    Vaccine. 2022 Jul 18. pii: S0264-410X(22)00888.
    >> Share

  121. PRIDDY FH, Williams M, Carson S, Lavender B, et al
    Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults.
    Vaccine. 2022 Jul 12. pii: S0264-410X(22)00885.
    >> Share

  122. NIESSEN FA, Knol MJ, Hahne SJM, Bonten MJM, et al
    Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands: A test-negative case-control study.
    Vaccine. 2022 Jun 8. pii: S0264-410X(22)00758.
    >> Share

  123. DUGORD C, Franc C
    Trajectories and individual determinants of repeated seasonal flu vaccination use over the long term using data from the French E3N cohort.
    Vaccine. 2022 Jul 18. pii: S0264-410X(22)00855.
    >> Share

  124. ORTQVIST AK, Dahlqwist E, Magnus MC, Ljung R, et al
    COVID-19 vaccination in pregnant women in Sweden and Norway.
    Vaccine. 2022 Jul 12. pii: S0264-410X(22)00859.
    >> Share

  125. BARRALL AL, Hoff NA, Nkamba DM, Musene K, et al
    Hesitancy to receive the novel coronavirus vaccine and potential influences on vaccination among a cohort of healthcare workers in the Democratic Republic of the Congo.
    Vaccine. 2022 Jul 1. pii: S0264-410X(22)00842.
    >> Share

  126. CUFFEL A, Maylin S, Le Buanec H, Delaugerre C, et al
    Humoral and cellular responses to SARS-CoV-2 BNT162b2 vaccination in allogeneic hematopoietic stem cell transplantation recipients.
    Vaccine. 2022 Jul 11. pii: S0264-410X(22)00857.
    >> Share

  127. PADRON-REGALADO E, Medina-Rivero E
    Perspectives for licensing vaccines in Mexico.
    Vaccine. 2022 Jul 11. pii: S0264-410X(22)00854.
    >> Share

  128. DE SWART RL, de Leeuw OS, Oreshkova N, Gerhards NM, et al
    Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters.
    Vaccine. 2022;40:4676-4681.
    >> Share

  129. OMER SB, O'Leary ST, Bednarczyk RA, Ellingson MK, et al
    Multi-tiered intervention to increase maternal immunization coverage: A randomized, controlled trial.
    Vaccine. 2022;40:4955-4963.
    >> Share

  130. BASS JR, Poland GA
    Shoulder injury related to vaccine administration (SIRVA) after COVID-19 vaccination.
    Vaccine. 2022 Jun 8. pii: S0264-410X(22)00750.
    >> Share

  131. SKIRROW H, Barnett S, Bell S, Mounier-Jack S, et al
    Women's views and experiences of accessing pertussis vaccination in pregnancy and infant vaccinations during the COVID-19 pandemic: A multi-methods study in the UK.
    Vaccine. 2022 Jul 1. pii: S0264-410X(22)00845.
    >> Share

  132. XIRIDOU M, Adam P, Meiberg A, Visser M, et al
    The impact of the COVID-19 pandemic on hepatitis B virus vaccination and transmission among men who have sex with men: A mathematical modelling study.
    Vaccine. 2022 Jul 4. pii: S0264-410X(22)00847.
    >> Share

  133. MCCORMICK DW, Konkle SL, Magleby R, Chakrabarti AK, et al
    SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge - Denver, Colorado, and San Diego, California, January-April 2021.
    Vaccine. 2022 Jul 4. pii: S0264-410X(22)00835.
    >> Share

  134. HILLS T, Paterson A, Woodward R, Middleton F, et al
    The effect of needle length and skin to deltoid muscle distance in adults receiving an mRNA COVID-19 vaccine.
    Vaccine. 2022 Jun 29. pii: S0264-410X(22)00839.
    >> Share

  135. MOUTA NUNES DE OLIVEIRA P, Mendes-de-Almeida DP, Bertollo Gomes Porto V, Crespo Cordeiro C, et al
    Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil.
    Vaccine. 2022 Jun 16. pii: S0264-410X(22)00761.
    >> Share

  136. MEDEIROS MZ, Soares PF, Fialho BC, Gauss L, et al
    Vaccine innovation model: A technology transfer perspective in pandemic contexts.
    Vaccine. 2022 Jun 27. pii: S0264-410X(22)00823.
    >> Share

  137. KORVES C, Izurieta HS, Smith J, Zwain GM, et al
    Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis.
    Vaccine. 2022 Jun 21. pii: S0264-410X(22)00816.
    >> Share

  138. AL-MUSTAPHA AI, Okechukwu O, Olayinka A, Muhammed OR, et al
    A national survey of COVID-19 vaccine acceptance in Nigeria.
    Vaccine. 2022 Jun 23. pii: S0264-410X(22)00818.
    >> Share

  139. LOHMANN S, Albarracin D
    Trust in the public health system as a source of information on vaccination matters most when environments are supportive.
    Vaccine. 2022 Jun 23. pii: S0264-410X(22)00759.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016